BUTALBITAL, ASPIRIN AND CAFFEINE
ASPIRIN; BUTALBITAL; CAFFEINE
Approval overview BUTALBITAL, ASPIRIN AND CAFFEINE is listed in Drugs@FDA under application 204195 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient ASPIRIN; BUTALBITAL; CAFFEINE Form and strength TABLET;ORAL - 325MG;50MG;40MG Sponsor STRIDES PHARMA Submission history Latest submission status date: 2024-11-21 00:00:00.
Structured Monograph
Clinical summary
Approval overview BUTALBITAL, ASPIRIN AND CAFFEINE is listed in Drugs@FDA under application 204195 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ASPIRIN; BUTALBITAL; CAFFEINE Form and strength TABLET;ORAL - 325MG;50MG;40MG Sponsor STRIDES PHARMA Submission history Latest submission status date: 2024-11-21 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.